Pay in 4 interest-free payments of $6.14 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
The FDA does not recognize it as a drug, biologic, or dietary supplement with an approved therapeutic claim
Interleukin-1 blockade by anakinra improves clinical symptoms in patients with neonatal-onset multisystem inflammatory disease
Temporary fatigue or flu-like symptoms occasionally accompany TB-500 initiation, particularly at higher doses
BPC-157 Oral Capsules are not approved for human or veterinary use by any regulatory agency
US$ 29.85
US$ 27.16
US$ 24.47
US$ 22.18
US$ 22.52
US$ 29.86
